Dallas-based Taysha Gene Therapies names board chair as new CEO


Sean P. Nolan, the chair of Taysha’s board, has been appointed CEO, succeeding RA Session II. Session resigned from his operational role but will continue on the board, according to a news release.

Previous Comerica economists say chance of a recession is 'four in five proposition'
Next Baptist Medical Center Clay opens doors to $234-milion facility